4.8 Article

IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data

Journal

NUCLEIC ACIDS RESEARCH
Volume 39, Issue -, Pages D534-D538

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkq1062

Keywords

-

Funding

  1. British Heart Foundation Centre of Research [RE/08/001]
  2. British Pharmacological Society
  3. Abbott
  4. GlaxoSmithKline
  5. Incyte
  6. Millipore
  7. Novartis
  8. Servier
  9. UNESCO
  10. Wyeth

Ask authors/readers for more resources

The IUPHAR database is an established online reference resource for several important classes of human drug targets and related proteins. As well as providing recommended nomenclature, the database integrates information on the chemical, genetic, functional and pathophysiological properties of receptors and ion channels, curated and peer-reviewed from the biomedical literature by a network of experts. The database now includes information on 616 gene products from four superfamilies in human and rodent model organisms: G protein-coupled receptors, voltage- and ligand-gated ion channels and, in a recent update, 49 nuclear hormone receptors (NHRs). New data types for NHRs include details on co-regulators, DNA binding motifs, target genes and 3D structures. Other recent developments include curation of the chemical structures of approximately 2000 ligand molecules, providing electronic descriptors, identifiers, link-outs and calculated molecular properties, all available via enhanced ligand pages. The interface now provides intelligent tools for the visualization and exploration of ligand structure-activity relationships and the structural diversity of compounds active at each target. The database is freely available at http://www.iuphar-db.org.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available